TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,862,356 | -0.1% | 1,736,416 | +1.5% | 4.12% | +2.0% |
| Q2 2023 | $26,881,782 | +111018.5% | 1,711,125 | +16.6% | 4.04% | +9.9% |
| Q1 2023 | $24,192 | +5.5% | 1,467,952 | -0.1% | 3.67% | +2.4% |
| Q4 2022 | $22,923 | -99.9% | 1,469,428 | +0.5% | 3.58% | +6.6% |
| Q3 2022 | $18,959,000 | -6.5% | 1,461,814 | +1.2% | 3.36% | +4.5% |
| Q2 2022 | $20,285,000 | +1.2% | 1,444,801 | +3.2% | 3.22% | +17.3% |
| Q1 2022 | $20,046,000 | +26.1% | 1,399,878 | +20.1% | 2.75% | +22.3% |
| Q4 2021 | $15,893,000 | -20.2% | 1,166,028 | -4.1% | 2.24% | -26.0% |
| Q3 2021 | $19,914,000 | -1.9% | 1,215,749 | +0.8% | 3.03% | +0.3% |
| Q2 2021 | $20,300,000 | +4.3% | 1,206,188 | +13.2% | 3.02% | -3.4% |
| Q1 2021 | $19,461,000 | +10.6% | 1,065,756 | +10.3% | 3.13% | +1.2% |
| Q4 2020 | $17,593,000 | +8.1% | 966,643 | +6.0% | 3.09% | -4.4% |
| Q3 2020 | $16,270,000 | +55.3% | 911,984 | +56.1% | 3.24% | +42.4% |
| Q2 2020 | $10,474,000 | +123.1% | 584,176 | +88.9% | 2.27% | +81.7% |
| Q1 2020 | $4,695,000 | – | 309,275 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |